|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2000-10-4
|
|
pubmed:abstractText |
To analyze the clinical utility of [11C]flumazenil (FMZ) PET to detect perilesional and remote cortical areas of abnormal benzodiazepine receptor binding in relation to MRI, 2-deoxy-2-[18F]fluoro-d-glucose (FDG) PET, and electrocorticographic (ECoG) findings as well as clinical characteristics of the epilepsy in epileptic patients with brain lesion.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0028-3878
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
26
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
825-35
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10994004-Adolescent,
pubmed-meshheading:10994004-Adult,
pubmed-meshheading:10994004-Child,
pubmed-meshheading:10994004-Child, Preschool,
pubmed-meshheading:10994004-Electroencephalography,
pubmed-meshheading:10994004-Epilepsy,
pubmed-meshheading:10994004-Female,
pubmed-meshheading:10994004-Flumazenil,
pubmed-meshheading:10994004-Fluorodeoxyglucose F18,
pubmed-meshheading:10994004-Humans,
pubmed-meshheading:10994004-Magnetic Resonance Imaging,
pubmed-meshheading:10994004-Male,
pubmed-meshheading:10994004-Tomography, Emission-Computed
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy.
|
|
pubmed:affiliation |
Departments of Pediatrics, Children's Hospital of Michigan, Detroit, MI 48201, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
